Chitosan-based nanoparticles for improving immunization against hepatitis B infection

Vaccine

Volumn 28, Issue 14, 2010, Pages 2607-2614

  Prego, Cecilia ^a   Paolicelli, Patrizia ^a   Díaz, Belen ^b   Vicente, Sara ^a   Sánchez, Alejandro ^a   González Fernández, África ^b   Alonso, María José ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

Author keywords

Adjuvant; Chitosan based nanoparticles; Subunit antigens

Indexed keywords

CHITOSAN; EPITOPE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; NANOPARTICLE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FREEZE DRYING; GELATION; HEPATITIS B; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHITOSAN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; IMMUNIZATION; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MICE; MICE, INBRED BALB C; NANOPARTICLES; VACCINES, SYNTHETIC;

EID: 77649186195     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.01.011     Document Type: Article

References (31)

1. Mahmoud A. The global vaccination. Science 305 5681 (2004) 147
2. Cohen J. Global health: the new world of global health. Science 311 5758 (2006) 162-167
3. Friede M., and Aguado M.T. Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems. Adv Drug Deliv Rev 57 3 (2005) 325-331
4. Zapata M.I., Peck G.E., White J.L., and Hem S.L. Mechanism of freeze-thaw instability of aluminium hydroxycarbonate and magnesium hydroxide gels. J Pharm Sci 73 1 (1984) 3-8
5. Maa Y.F., Zhao L., Payne L.G., and Chen D. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application. J Pharm Sci 92 2 (2003) 319-332
6. Maa Y.F., Ameri M., Rigney R., Payne L.G., and Chen D. Spray-coating for biopharmaceutical powder formulations: beyond the conventional scale and its application. Pharm Res 21 3 (2004) 515-523
7. Alonso M.J., Cohen S., Park T.G., Gupta R.K., Siber G.R., and Langer R. Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm Res 10 7 (1993) 945-953
8. Shi L., Caufield M.J., Chern R.T., Wilson R.A., Sanyal G., and Volkin D.B. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres. J Pharm Sci 91 4 (2002) 1019-1035
9. Feng L., Qi X.R., Zhou X.J., Maitani Y., Wang S.S.C., Jiang Y., et al. Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release 112 1 (2006) 35-42
10. O'Hagan D.T., and Valiante N.M. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev Drug Discov 2 9 (2003) 727-735
11. Tong N.K., Beran J., Kee S.A., Miguel J.L., Sánchez C., Bayas J.M., et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 68 5 (2005) 2298-2303
12. Giudice E.L., and Campbell J.D. Needle-free vaccine delivery. Adv Drug Deliv Rev 58 1 (2006) 68-89
13. Neutra M.R., and Kozlowski P.A. Mucosal vaccines: the promise and the challenge. Nat Rev Immunol 6 2 (2006) 148-158
14. Kiyono H., and Fukuyama S. Nalt-versus Peyer's-Patch-mediated mucosal immunity. Nat Rev Immunol 4 9 (2004) 699-710
15. Vila A., Sanchez A., Tobio M., Calvo P., and Alonso M.J. Design of biodegradable particles for protein delivery. J Control Release 78 1-3 (2002) 15-24
16. Vila A., Sanchez A., Janes K.A., Behrens I., Kissel T., Vila Jato J.L., et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery. Eur J Pharm Biopharm 57 1 (2004) 123-132
17. Calvo P., Remuñan-Lopez C., Vila Jato J.L., and Alonso M.J. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 63 1 (1997) 125-132
18. Calvo P., Remuñan-Lopez C., Vila Jato J.L., and Alonso M.J. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res 14 10 (1997) 1431-1436
19. Fernandez-Urrusuno R., Calvo P., Remuñan-Lopez C., Vila Jato J.L., and Alonso M.J. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res 16 10 (1999) 1576-1581
20. Janes K.A., Calvo P., and Alonso M.J. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev 47 1 (2001) 83-97
21. Prego C., Torres D., and Alonso M.J. The potential of chitosan for the oral administration of peptides. Expert Opin Drug Deliv 2 5 (2005) 843-854
22. Grgacic E.V., and Anderson D.A. Virus-like particles: passport to immune recognition. Methods 40 1 (2006) 60-65
23. Shouval D. Hepatitis B vaccines. J Hepatol 39 1 (2003) S70-S76
24. Gavilanes F., Gonzalez-Ros J.M., and Peterson D.L. Structure of hepatitis B surface antigen. J Biol Chem 257 13 (1982) 7770-7777
25. Wang S., Liu X., Fisher K., Smith J.G., Chen F., Tobery T.W., et al. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminium phosphate. Vaccine 18 13 (2000) 1227-1235
26. Katakam M., and Banga A.K. Use of poloxamer polymers to stabilize recombinant human growth hormone against various processing stresses. Pharm Dev Technol 2 2 (1997) 143-149
27. Kang M.L., Jiang H.L., Kang S.G., Guo D.D., Lee D.Y., Cho C.S., et al. Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin. Vaccine 25 23 (2007) 4602-4610
28. Coeshott C.M., Smithson S.L., Verderber E., Samaniego A., Blonder J.M., Rosenthal G.J., et al. Pluronic F127-based systemic vaccine delivery systems. Vaccine 22 19 (2004) 2396-2405
29. Westerink M.A., Smithson S.L., Srivastava N., Blonder J., Coeshott C., and Rosenthal G.J. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid. Vaccine 20 5-6 (2001) 711-723
30. Fernandez-Urrusuno R., Romani D., Calvo P., Vila-Jato J.L., and Alonso M.J. Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration. STP Pharma Sci 9 (1999) 429-436
31. Cuña M., Alonso-Sande M., Remuñan-Lopez C., Pivel J.P., Alonso-Lebrero J.L., and Alonso M.J. Development of phosphorylated glucomannan-coated chitosan nanoparticles as nanocarriers for protein delivery. J Nanosci Nanotechnol 6 9-10 (2006) 2887-2895